180 related articles for article (PubMed ID: 29407486)
1. Antiviral and anti-inflammatory activity of budesonide against human rhinovirus infection mediated via autophagy activation.
Kim SR; Song JH; Ahn JH; Lee GS; Ahn H; Yoon SI; Kang SG; Kim PH; Jeon SM; Choi EJ; Shin S; Cha Y; Cho S; Kim DE; Chang SY; Ko HJ
Antiviral Res; 2018 Mar; 151():87-96. PubMed ID: 29407486
[TBL] [Abstract][Full Text] [Related]
2. Antiviral activity of gemcitabine against human rhinovirus in vitro and in vivo.
Song JH; Kim SR; Heo EY; Lee JY; Kim DE; Cho S; Chang SY; Yoon BI; Seong J; Ko HJ
Antiviral Res; 2017 Sep; 145():6-13. PubMed ID: 28705625
[TBL] [Abstract][Full Text] [Related]
3. Trehalose-mediated autophagy impairs the anti-viral function of human primary airway epithelial cells.
Wu Q; Jiang D; Huang C; van Dyk LF; Li L; Chu HW
PLoS One; 2015; 10(4):e0124524. PubMed ID: 25879848
[TBL] [Abstract][Full Text] [Related]
4. Formoterol and budesonide inhibit rhinovirus infection and cytokine production in primary cultures of human tracheal epithelial cells.
Yamaya M; Nishimura H; Nadine L; Kubo H; Nagatomi R
Respir Investig; 2014 Jul; 52(4):251-60. PubMed ID: 24998372
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol inhibits rhinovirus replication and expression of inflammatory mediators in nasal epithelia.
Mastromarino P; Capobianco D; Cannata F; Nardis C; Mattia E; De Leo A; Restignoli R; Francioso A; Mosca L
Antiviral Res; 2015 Nov; 123():15-21. PubMed ID: 26296578
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic and prophylactic activity of itraconazole against human rhinovirus infection in a murine model.
Shim A; Song JH; Kwon BE; Lee JJ; Ahn JH; Kim YJ; Rhee KJ; Chang SY; Cha Y; Lee YS; Kweon MN; Park KS; Kim DE; Cho S; Cho HJ; Ko HJ
Sci Rep; 2016 Mar; 6():23110. PubMed ID: 26976677
[TBL] [Abstract][Full Text] [Related]
7. Rhinovirus-induced airway inflammation in asthma: effect of treatment with inhaled corticosteroids before and during experimental infection.
Grünberg K; Sharon RF; Sont JK; In 't Veen JC; Van Schadewijk WA; De Klerk EP; Dick CR; Van Krieken JH; Sterk PJ
Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 1):1816-22. PubMed ID: 11734429
[TBL] [Abstract][Full Text] [Related]
8. Drug targets in rhinoviral infections.
Rohde G
Infect Disord Drug Targets; 2009 Apr; 9(2):126-32. PubMed ID: 19275701
[TBL] [Abstract][Full Text] [Related]
9. Chronic IL-33 expression predisposes to virus-induced asthma exacerbations by increasing type 2 inflammation and dampening antiviral immunity.
Werder RB; Zhang V; Lynch JP; Snape N; Upham JW; Spann K; Phipps S
J Allergy Clin Immunol; 2018 May; 141(5):1607-1619.e9. PubMed ID: 28947081
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Virus-Induced Cytokine Production from Airway Epithelial Cells by the Late Addition of Budesonide.
Homma T; Fukuda Y; Uchida Y; Uno T; Jinno M; Kishino Y; Yamamoto M; Sato H; Akimoto K; Kaneko K; Fujiwara A; Sato H; Hirai K; Miyata Y; Inoue H; Ohta S; Watanabe Y; Kusumoto S; Ando K; Suzuki S; Yamaoka T; Tanaka A; Ohmori T; Sagara H
Medicina (Kaunas); 2020 Feb; 56(3):. PubMed ID: 32120846
[TBL] [Abstract][Full Text] [Related]
11. Rhinovirus chemotherapy.
Patick AK
Antiviral Res; 2006 Sep; 71(2-3):391-6. PubMed ID: 16675037
[TBL] [Abstract][Full Text] [Related]
12. α1-Antitrypsin reduces rhinovirus infection in primary human airway epithelial cells exposed to cigarette smoke.
Berman R; Jiang D; Wu Q; Chu HW
Int J Chron Obstruct Pulmon Dis; 2016; 11():1279-86. PubMed ID: 27354786
[TBL] [Abstract][Full Text] [Related]
13. Quercetin inhibits rhinovirus replication in vitro and in vivo.
Ganesan S; Faris AN; Comstock AT; Wang Q; Nanua S; Hershenson MB; Sajjan US
Antiviral Res; 2012 Jun; 94(3):258-71. PubMed ID: 22465313
[TBL] [Abstract][Full Text] [Related]
14. A synthetic STING agonist inhibits the replication of human parainfluenza virus 3 and rhinovirus 16 through distinct mechanisms.
Zhu Q; Hu H; Liu H; Shen H; Yan Z; Gao L
Antiviral Res; 2020 Nov; 183():104933. PubMed ID: 32949635
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of novel antibody-based drugs against rhinovirus infection: In vitro and in vivo results.
Petrova NV; Emelyanova AG; Gorbunov EA; Edwards MR; Walton RP; Bartlett NW; Aniscenko J; Gogsadze L; Bakhsoliani E; Khaitov MR; Johnston SL; Tarasov SA; Epstein OI
Antiviral Res; 2017 Jun; 142():185-192. PubMed ID: 28356234
[TBL] [Abstract][Full Text] [Related]
16. Budesonide and formoterol inhibit inflammatory mediator production by bronchial epithelial cells infected with rhinovirus.
Skevaki CL; Christodoulou I; Spyridaki IS; Tiniakou I; Georgiou V; Xepapadaki P; Kafetzis DA; Papadopoulos NG
Clin Exp Allergy; 2009 Nov; 39(11):1700-10. PubMed ID: 19549024
[TBL] [Abstract][Full Text] [Related]
17. Identification of a Novel Inhibitor of Human Rhinovirus Replication and Inflammation in Airway Epithelial Cells.
Yang Z; Bochkov YA; Voelker DR; Foster MW; Que LG
Am J Respir Cell Mol Biol; 2019 Jan; 60(1):58-67. PubMed ID: 30156431
[TBL] [Abstract][Full Text] [Related]
18. No exacerbation but impaired anti-viral mechanisms in a rhinovirus-chronic allergic asthma mouse model.
Rochlitzer S; Hoymann HG; Müller M; Braun A;
Clin Sci (Lond); 2014 Jan; 126(1):55-65. PubMed ID: 23822145
[TBL] [Abstract][Full Text] [Related]
19. Anti-human rhinovirus activity of gallic acid possessing antioxidant capacity.
Choi HJ; Song JH; Bhatt LR; Baek SH
Phytother Res; 2010 Sep; 24(9):1292-6. PubMed ID: 20104501
[TBL] [Abstract][Full Text] [Related]
20. Ambroxol inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells.
Yamaya M; Nishimura H; Nadine LK; Ota C; Kubo H; Nagatomi R
Arch Pharm Res; 2014 Apr; 37(4):520-9. PubMed ID: 23856970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
